In-house homologous recombination deficiency testing in ovarian cancer: a multi-institutional Italian pilot study

Pepe, F; Guerini-Rocco, E; Fassan, M; Fusco, N; Vacirca, D; Ranghiero, A; Venetis, K; Rappa, A; Taormina, SV; Russo, G; Rebellato, E; Munari, G; Moreno-Manuel, A; De Angelis, C; Zamagni, C; Valabrega, G; Malapelle, U; Troncone, G; Barberis, M; Iaccarino, A

Malapelle, U (通讯作者),Univ Naples Federico II, Publ Hlth, I-80131 Naples, Italy.

JOURNAL OF CLINICAL PATHOLOGY, 2023; ():

Abstract

AimsPoly (ADP-ribose) polymerase (PARP) inhibitors (PARPIs) represent a standard of care for the clinical management of high-grade serous ovarian canc......

Full Text Link